Skip to main content
Clinical Trials/NCT03445741
NCT03445741
Completed
Not Applicable

Effects of Different Intensities and Durations of Aerobic Exercise Training and Detraining on Metabolic, Hormonal Responses and Abdominal Obesity in Women With Metabolic Syndrome.

Pamukkale University0 sites60 target enrollmentAugust 1, 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Metabolic Syndrome
Sponsor
Pamukkale University
Enrollment
60
Primary Endpoint
*Change from baseline in weight (kilograms) at week 12 and 4- week detraining period.
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

Objective: To show metabolic and hormonal responses and effects on abdominal obesity of aerobic exercise in different intensity and duration and detraining period in women with metabolic syndrome.

Detailed Description

Objective: To show metabolic and hormonal responses and effects on abdominal obesity of aerobic exercise in different intensity and duration and detraining period in women with metabolic syndrome. Methods: Fifty-one women with metabolic syndrome were divided into three groups: 12 weekly sessions of high intensity supervised treadmill group, respectively, at % 70 of maximum oxygen consumption (group I, n=17), low intensity supervised treadmill group, respectively at % 50 of maximum oxygen consumption (group II, n=17) and walking at low intensity, respectively at % 50 of maximum oxygen consumption with ECEPEDO pedometer (group III, n=17). Target heart rate (HR) corresponding to values of 50-70 % VO2max were determined by the submaximal treadmill test. Group 1 and 2 were instructed walking at their target HR on a treadmill. The number of steps taken in a minute corresponding to target HR was determined by a criterion pedometer and group 3 was instructed walking in this step range recorded to ECE PEDO giving audible feedback. Participants were evaluated by weight, BMI, waist circumference (WC), blood sugar, LDL, HDL and triglyceride; viseral fat, trunk fat and waist circumference by bioelectrical impedance device (VIScan); ergospirometric VO2max at baseline, 12-week and 4-week detraining period.

Registry
clinicaltrials.gov
Start Date
August 1, 2016
End Date
June 1, 2018
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Füsun Ardıç

Professor M.D.

Pamukkale University

Eligibility Criteria

Inclusion Criteria

  • eligible participants who meet the criteria for inclusion were women with metabolic syndrome diagnosis according to National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) criteria and were 25-65 years old.
  • Participants were well communicative, motivated and willing to participate in the study.

Exclusion Criteria

  • The exclusion criteria were presence of uncontrolled hypertension, type 2 diabetes mellitus, atherosclerotic heart disease, using drugs to affect thyroid, lipids metabolism and insulin sensitization, musculoskeletal or systemic diseases contradicting the exercise, a neurological or psychiatric disease affecting cooperation and cognitive function.

Outcomes

Primary Outcomes

*Change from baseline in weight (kilograms) at week 12 and 4- week detraining period.

Time Frame: Week 12 and week 16

Weight was measured with weight scale.

*Change from baseline in free fatty acide parameter at week 12 and 4- week detraining period.

Time Frame: Week 12 and week 16

Fasting blood samples were collected at morning hours before exercise testing. To perform free fatty acide values, a sum of blood were stored at -80 C for later study.

*Change from baseline in abdominal viseral fat and trunk fat and measured by VIScan at week 12 and 4-week detraining period.

Time Frame: Week 12 and week 16

BIA device ViScan, designed to estimate visceral adiposity and trunk fat percentage. A wireless 'electrode belt' is placed on the bare midriff of the subject in supine position. The belt then uses dual frequency bio impedance (6.25 and 50 kHz) to measure trunk and visceral fat resistance and transmit the readings via infrared to the base unit.

*Change from baseline in noradrenaline parameter at week 12 and 4- week detraining period.

Time Frame: Week 12 and week 16

Fasting blood samples were collected at morning hours before exercise testing. To perform noradrenaline values, a sum of blood were stored at -80 C for later study.

*Change from baseline in Epinephrine/Adrenaline parameter at week 12 and 4- week detraining period.

Time Frame: Week 12 and week 16

Fasting blood samples were collected at morning hours before exercise testing. To perform adrenaline values, a sum of blood were stored at -80 C for later study.

*Change from baseline in oxyntomodulin parameter at week 12 and 4- week detraining period.

Time Frame: Week 12 and week 16

Fasting blood samples were collected at morning hours before exercise testing. To perform oxyntomodulin values, a sum of blood were stored at -80 C for later study.

*Change from baseline in glycerol parameter at week 12 and 4- week detraining period.

Time Frame: Week 12 and week 16

Fasting blood samples were collected at morning hours before exercise testing. To perform glycerol values, a sum of blood were stored at -80 C for later study.

Similar Trials